Physician profile
Larry A Stern
NPI 1437151388
$2,230.34
in general payments reported to CMS, 2019-2025
14 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $686 · 2020: $420 · 2021: $471 · 2022: $345 · 2023: $80.14 · 2024: $111 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $508.90 | 2019-2021 | |
| Organogenesis INC. | $416.91 | 2019-2024 | Apligraf, Puraply |
| Bioventus LLC | $405.95 | 2022-2023 | |
| Integra Lifesciences Corporation | $359.94 | 2019-2025 | Tcc-Ez |
| Kci USA, INC. | $225.65 | 2019 | |
| Smith+Nephew, INC. | $129.85 | 2019-2025 | Renasys Go V2 Home |
| Kerecis Limited | $44.73 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Lifenet Health | $30.32 | 2024 | Theragenesis Wound Matrix |
| Paratek Pharmaceuticals, INC. | $23.29 | 2025 | Nuzyra |
| Angiodynamics, INC. | $19.95 | 2019 | |
| Amgen INC. | $18.50 | 2024 | Krystexxa |
| Solventum Corporation | $17.88 | 2025 | Activ.A.C. |
| Mimedx Group, INC. | $15.57 | 2025 | |
| Medline Industries LP | $12.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Stern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.